CFChristine Frithioff-Bøjsøe

Christine Frithioff-Bøjsøe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christine Frithioff-Bøjsøe has a total of 187 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early detection of childhood overweight and related complications in a Danish population-based cohort aged 2–8 years

    by Christine Frithioff-Bøjsøe, Morten Asp Vonsild Lund, Ulrik Lausten-Thomsen, Cilius Esmann Fonvig, Ida Olivia Juhl Lankjær, Tina Hansen, Torben Hansen, Jennifer Lyn Baker, Jens-Christian Holm


  • Open Access

    Neonatal Anthropometrics and Obesity Treatment Response in Children and Adolescents

    by Ulrik Lausten-Thomsen, Morten Asp Vonsild Lund, Sara Elizabeth Stinson, Christine Frithioff-Bøjsøe, Louise Aas Holm, Jennifer Lyn Baker, Cilius Esmann Fonvig, Michael Christiansen, Lars Ängquist, Torben Hansen, et al.


  • Open Access

    Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations

    by Cæcilie Trier, Mette Hollensted, Theresia M. Schnurr, Morten Asp Vonsild Lund, Tenna Ruest Haarmark Nielsen, Gao Rui, Ehm Astrid Andersson, Mathilde Svendstrup, Dorthe Sadowa Bille, Anette P. Gjesing, et al.

    Objectives: To determine the prevalence of Melanocortin-4 Receptor (MC4R) mutations in a cohort of children and adolescents with overweight or obesity and to determine whether treatment responses differed between carriers and noncarriers. Methods: Using target region capture sequencing, an MC4R mutation screen was performed in 1261 Danish children and adolescents enrolled at a tertiary multidisciplinary childhood obesity treatment center. Measurements of anthropometrics, blood pressure, fasting blood biochemistry including lipid and hormone levels, and dual-energy X-ray absorptiometry were performed at baseline and throughout treatment. Results: Of 1209 children and adolescents that met all criteria to be included in the described analyses, 30 (2.5%) carried damaging or unresolved MC4R mutations. At baseline, mutation carriers exhibited higher concentrations of plasma thyroid-stimulating hormone (p = 0.003), and lower concentrations of plasma thyroxine (p = 0.010) compared to noncarriers. After a median of 1 year of treatment (range 0.5–4.0 years), body mass index (BMI) standard deviation score (SDS) was reduced in noncarriers but not in carriers, and this difference in treatment response was statistically significant (p = 0.005). Furthermore, HDL cholesterol was reduced in carriers, a response significantly different from that of noncarriers (p = 0.017). Conclusion: Among Danish children and adolescents with overweight or obesity entering a tertiary lifestyle intervention, 2.5% carried damaging or unresolved MC4R mutations. In contrast to noncarriers, carriers of damaging or unresolved MC4R mutations failed to reduce their BMI SDS during obesity treatment, indicating a need for personalized treatment based on the MC4R genotype.


  • Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity

    by Christine Frithioff‐Bøjsøe, Morten Asp Vonsild Lund, Ulrik Lausten‐Thomsen, Paula Louise Hedley, Oluf Pedersen, Michael Christiansen, Jennifer Lyn Baker, Torben Hansen, Jens‐Christian Holm

    Background It is imperative to develop markers for risk stratification and detection of cardiometabolic comorbidities in children with obesity. The adipokines leptin and adiponectin are both involved in fat mass regulation and the development of obesity‐related disorders, furthermore, their ratio (L/A ratio) is suggested to be associated with insulin resistance and cardiometabolic risk. Objective To evaluate associations between fasting serum concentrations of the adipokines (total leptin and adiponectin as well as the L/A ratio) and cardiometabolic comorbidities in children with overweight/obesity. Methods 2,258 children with overweight/obesity or normal weight aged 6‐18 years were studied. Differences in anthropometrics and adipokine concentrations were tested using Wilcoxon rank‐sum test. Associations between the adipokines and cardiometabolic risk were tested using Spearman's correlation and logistic regression, adjusted for age and BMI‐SDS. Results Compared to normal weight children; children with overweight/obesity exhibited higher leptin concentrations, lower adiponectin concentrations and higher L/A ratios. After adjusting for age and degree of obesity, girls with overweight/obesity in the upper quartile range for the L/A ratio, when compared with girls in the lower quartile range, were more likely to have insulin resistance (OR: 7.78 [95% CI, 3.78‐16.65]), dysglycemia (OR: 3.08 [95% CI, 1.35‐7.31]), and dyslipidemia (OR: 2.53 [95% CI, 1.18‐5.59]); while boys were more likely to have insulin resistance (OR: 4.45 [95% CI, 2.03‐10.10]). Conclusions Independent of the degree of obesity, leptin, adiponectin, and the L/A ratio were associated with insulin resistance and other cardiometabolic comorbidities in children with overweight/obesity, but the L/A ratio exhibited stronger associations than the respective adipokines.


  • Abdominal adiposity and cardiometabolic risk factors in children and adolescents: a Mendelian randomization analysis

    by Anna Viitasalo, Theresia M Schnurr, Niina Pitkänen, Mette Hollensted, Tenna Rh Nielsen, Katja Pahkala, Mustafa Atalay, Mads V Lind, Sami Heikkinen, Christine Frithioff-Bøjsøe, et al.

    Mendelian randomization studies in adults suggest that abdominal adiposity is causally associated with increased risk of type 2 diabetes and coronary artery disease in adults, but its causal effect on cardiometabolic risk in children remains unclear. We aimed to study the causal relation of abdominal adiposity with cardiometabolic risk factors in children by applying Mendelian randomization. We constructed a genetic risk score (GRS) using variants previously associated with waist-to-hip ratio adjusted for BMI (WHRadjBMI) and examined its associations with cardiometabolic factors by linear regression and Mendelian randomization in a meta-analysis of 6 cohorts, including 9895 European children and adolescents aged 3-17 y. WHRadjBMI GRS was associated with higher WHRadjBMI (β = 0.021 SD/allele; 95% CI: 0.016, 0.026 SD/allele; P = 3 × 10-15) and with unfavorable concentrations of blood lipids (higher LDL cholesterol: β = 0.006 SD/allele; 95% CI: 0.001, 0.011 SD/allele; P = 0.025; lower HDL cholesterol: β = -0.007 SD/allele; 95% CI: -0.012, -0.002 SD/allele; P = 0.009; higher triglycerides: β = 0.007 SD/allele; 95% CI: 0.002, 0.012 SD/allele; P = 0.006). No differences were detected between prepubertal and pubertal/postpubertal children. The WHRadjBMI GRS had a stronger association with fasting insulin in children and adolescents with overweight/obesity (β = 0.016 SD/allele; 95% CI: 0.001, 0.032 SD/allele; P = 0.037) than in those with normal weight (β = -0.002 SD/allele; 95% CI: -0.010, 0.006 SD/allele; P = 0.605) (P for difference = 0.034). In a 2-stage least-squares regression analysis, each genetically instrumented 1-SD increase in WHRadjBMI increased circulating triglycerides by 0.17 mmol/L (0.35 SD, P = 0.040), suggesting that the relation between abdominal adiposity and circulating triglycerides may be causal. Abdominal adiposity may have a causal, unfavorable effect on plasma triglycerides and potentially other cardiometabolic risk factors starting in childhood. The results highlight the importance of early weight management through healthy dietary habits and physically active lifestyle among children with a tendency for abdominal adiposity.


  • Open Access

    Genetic predisposition to higher body fat yet lower cardiometabolic risk in children and adolescents

    by Anna Viitasalo, Theresia M. Schnurr, Niina Pitkänen, Mette Hollensted, Tenna R. H. Nielsen, Katja Pahkala, Niina Lintu, Mads V. Lind, Mustafa Atalay, Christine Frithioff-Bøjsøe, et al.

    Background: Most obese children show cardiometabolic impairments, such as insulin resistance, dyslipidemia, and hypertension. Yet some obese children retain a normal cardiometabolic profile. The mechanisms underlying this variability remain largely unknown. We examined whether genetic loci associated with increased insulin sensitivity and relatively higher fat storage on the hip than on the waist in adults are associated with a normal cardiometabolic profile despite higher adiposity in children. Methods: We constructed a genetic score using variants previously linked to increased insulin sensitivity and/or decreased waist–hip ratio adjusted for body mass index (BMI), and examined the associations of this genetic score with adiposity and cardiometabolic impairments in a meta-analysis of six cohorts, including 7391 European children aged 3–18 years. Results: The genetic score was significantly associated with increased degree of obesity (higher BMI-SDS beta = 0.009 SD/allele, SE = 0.003, P = 0.003; higher body fat mass beta = 0.009, SE = 0.004, P = 0.031), yet improved body fat distribution (lower WHRadjBMI beta = −0.014 SD/allele, SE = 0.006, P = 0.016), and favorable concentrations of blood lipids (higher HDL cholesterol: beta = 0.010 SD/allele, SE = 0.003, P = 0.002; lower triglycerides: beta = −0.011 SD/allele, SE = 0.003, P = 0.001) adjusted for age, sex, and puberty. No differences were detected between prepubertal and pubertal/postpubertal children. The genetic score predicted a normal cardiometabolic profile, defined by the presence of normal glucose and lipid concentrations, among obese children (OR = 1.07 CI 95% 1.01–1.13, P = 0.012, n = 536). Conclusions: Genetic predisposition to higher body fat yet lower cardiometabolic risk exerts its influence before puberty.


  • Open Access

    A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity

    by Jonathan P Bradfield, Suzanne Vogelezang, Janine F Felix, Alessandra Chesi, Øyvind Helgeland, Momoko Horikoshi, Ville Karhunen, Estelle Lowry, Diana L Cousminer, Tarunveer S Ahluwalia, et al.

    Although hundreds of genome-wide association studies-implicated loci have been reported for adult obesity-related traits, less is known about the genetics specific for early-onset obesity and with only a few studies conducted in non-European populations to date. Searching for additional genetic variants associated with childhood obesity, we performed a trans-ancestral meta-analysis of 30 studies consisting of up to 13 005 cases (≥95th percentile of body mass index (BMI) achieved 2–18 years old) and 15 599 controls (consistently METTL15). The variant was nominally associated with only the European subgroup analysis but had a consistent direction of effect in other ethnicities. We then utilized trans-ancestral Bayesian analysis to narrow down the location of the probable causal variant at each genome-wide significant signal. Of all the fine-mapped loci, we were able to narrow down the causative variant at four known loci to fewer than 10 single nucleotide polymorphisms (SNPs) (FAIM2, GNPDA2, MC4R and SEC16B loci). In conclusion, an ethnically diverse setting has enabled us to both identify an additional pediatric obesity locus and further fine-map existing loci.


  • Reference values for leptin/adiponectin ratio in healthy children and adolescents

    by Ulrik Lausten-Thomsen, Morten Asp Vonsild Lund, Christine Frithioff-Bøjsøe, Paula Louise Hedley, Oluf Pedersen, Torben Hansen, Michael Christiansen, Jens-Christian Holm


  • Glucose metabolism in children and adolescents: Population‐based reference values and comparisons to children and adolescents enrolled in obesity treatment

    by Christine Frithioff‐Bøjsøe, Morten A. V. Lund, Julie T. Kloppenborg, Tenna T. H. Nielsen, Cilius E. Fonvig, Ulrik Lausten‐Thomsen, Paula L. Hedley, Tina Hansen, Oluf B. Pedersen, Michael Christiansen, et al.

    Background Alterations in glucose metabolism that lead to the development of metabolic and cardiovascular disease may begin already in childhood. Objective This study aims to generate pediatric age and sex‐specific reference values for fasting concentrations of glucose, hemoglobin A1c (HbA1c), insulin, C‐peptide, and homeostasis model assessment: insulin resistance (HOMA‐IR) in Danish/North‐European white children and adolescents from a population‐based cohort and to compare values from children and adolescents with overweight/obesity with this reference. Methods The population‐ and obesity clinic‐based cohorts consisted of 2451 and 1935 children and adolescents between 6 and 18 years of age. Anthropometric measurements and blood samples were obtained and percentile curves were calculated. Results In the population‐based cohort, glucose, insulin, and HOMA‐IR values increased before the expected onset of puberty (P < .05). Thereafter, all variables decreased in girls (P < .05) and HbA1c decreased in boys (P < .05). Concentrations of all measured markers of glucose metabolism were higher in the obesity clinic‐based cohort than the population‐based cohort (both sexes P < .001). Specifically, insulin and HOMA‐IR continued to increase to 18 years in the clinic‐based cohort, particularly among boys. Conclusions Fasting glucose, insulin, and HOMA‐IR change during childhood, making pediatric reference values essential for timely identification of derangements in glucose metabolism. Children and adolescents with obesity exhibit increased concentrations of these biomarkers.


  • Reference values for fasting serum concentrations of thyroid-stimulating hormone and thyroid hormones in healthy Danish/North-European white children and adolescents

    by Gowthami Gunapalasingham, Christine Frithioff-Bøjsøe, Morten Asp Vonsild Lund, Paula Louise Hedley, Cilius Esmann Fonvig, Maria Dahl, Oluf Pedersen, Michael Christiansen, Torben Hansen, Ulrik Lausten-Thomsen, et al.

    Thyroid-stimulating hormone (TSH) and thyroid hormones influence the functions of many organ systems, as well as child development and growth. Several studies have reported an association between ethnicity and thyroid hormones. This study aims to explore pediatric serum concentrations of TSH, free triiodothyronine (fT3), and free thyroxine (fT4) and their relation to age and sex and subsequently to present pediatric reference intervals from healthy Danish/North-European white children. A population-based cohort in Denmark of 2411 (1435 girls) healthy school children and adolescents aged 6.0–18.9 years were included. Fasting concentrations of serum TSH, fT3, and fT4 were determined from venous blood samples using immunologic chemiluminescent assays. Age- and sex-dependent percentiles were generated using the GAMLSS function. Median values of fT3 and fT4, but not TSH, were lower in the older age group compared with the youngest age group for both sexes (all p < .05). A significant difference for fT3 was found between the sexes for all age groups (all p < .001). fT4 was negatively correlated with body mass index standard deviation scores in boys. In conclusion, serum concentrations of thyroid hormones vary during childhood and adolescence and differ with age and sex.